CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome

Int J Clin Exp Pathol. 2014 Apr 15;7(5):1988-96. eCollection 2014.

Abstract

Objective: To examine amount of CD4+CXCR5+Tfh cells and B cells subsets in salivary gland and peripheral blood from patients with primary Sjogren's syndrome (pSS) and to analyze whether the frequency of CD4+CXCR5+Tfh cells is associated with pSS pathologic process.

Methods: The percentages of CD4+CXCR5+Tfh cells and B cell subsets were examined by flow cytometry. B-lymphocyte chemoattraetant (BLC; also called CXCL13), IL-21, IL-6 from the serum of pSS patients was assessed by polymerase chain reaction-enzyme-linked immunosorbent assay (ELISA).

Results: The percentages of CD4+CXCR5+Tfh cells in peripheral blood were increased in pSS patients, but decreased after treatment with glucocorticoid and/or immunosuppressive drugs. Abnormal B cell subsets appeared in salivary and peripheral blood of pSS patients. The frequency of salivary CD4+CXCR5+Tfh cells was positively correlated with CD19+CD27+ memory B cells and CD19+CD27high plasma cells. Also increase of salivary CD19+CD27high plasma cells was positively associated with serum ANA titer of pSS patients.

Conclusions: CD4+CXCR5+Tfh cells are significantly increased in salivary and peripheral blood in pSS patients with aberrant CD19+CD27+ memory B cells and CD19+CD27high plasma cells, suggesting that CD4+CXCR5+Tfh cells may contribute to the pathogenesis of pSS by promoting the maturation of B cells.

Keywords: B cell; Sjogren’s syndrome; follicular helper T cell; germinal center.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antigens, CD19 / blood
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / metabolism
  • Biomarkers / blood
  • CD4 Lymphocyte Count
  • Case-Control Studies
  • Cell Communication* / drug effects
  • Cytokines / blood
  • Female
  • Flow Cytometry
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Receptors, CXCR5 / blood*
  • Salivary Glands / drug effects
  • Salivary Glands / immunology*
  • Salivary Glands / metabolism
  • Salivary Glands / pathology
  • Signal Transduction
  • Sjogren's Syndrome / blood
  • Sjogren's Syndrome / drug therapy
  • Sjogren's Syndrome / immunology*
  • Sjogren's Syndrome / pathology
  • T-Lymphocytes, Helper-Inducer / drug effects
  • T-Lymphocytes, Helper-Inducer / immunology*
  • T-Lymphocytes, Helper-Inducer / metabolism
  • Treatment Outcome
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 / blood

Substances

  • Antigens, CD19
  • Biomarkers
  • CXCR5 protein, human
  • Cytokines
  • Glucocorticoids
  • Immunosuppressive Agents
  • Receptors, CXCR5
  • Tumor Necrosis Factor Receptor Superfamily, Member 7